Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-07

Clinical Trial Update: Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients [NA]

View source ↗

Summary

A completed study comparing the Finesse insulin dosing device to traditional insulin pens for initiating bolus insulin in adults with Type 2 diabetes, reporting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Finesse
  • insulin pen (insulin pen)

Snippet

Sponsor: Calibra Medical, Inc. | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2018-11-07